COMMUNIQUÉS West-GlobeNewswire

OHSU and Aptose Present CG’806 Preclinical Data at ASH 59th Annual Meeting

11/12/2017 - 22:04

PORTLAND, Ore. and SAN DIEGO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- The OHSU Knight Cancer Institute and Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS ) today announced the presentation of preclinical data demonstrating [...]

Transparency notification

11/12/2017 - 22:02

Mechelen, Belgium; 11 December 2017; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Fidelity Management & Research (FMR) LLC. Pursuant to [...]

Achaogen Appoints Blake Wise Chief Executive Officer

11/12/2017 - 22:01

- Dr. Kenneth Hillan to become President, R&D - - Succession designed to lead Achaogen through next phase of growth as a commercial-stage company - - Transition effective January 1, 2018 - SOUTH SAN FRANCISCO, Calif [...]

Fibrocell Announces Closing of $10.5 Million Underwritten Public Offering

11/12/2017 - 22:01

EXTON, Pa., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round

11/12/2017 - 22:01

JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer, [...]

156 Genesis HealthCare Sites Earn National Quality Improvement Recognition

11/12/2017 - 22:01

KENNETT SQUARE, Pa., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Genesis HealthCare , one of the largest post-acute providers in the United States, today announced that 156 of its skilled nursing centers and senior living [...]

Aduro Biotech to Host a Program Update Call

11/12/2017 - 22:01

BERKELEY, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today announced that the company will host a [...]

Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

11/12/2017 - 22:01

NEWTON, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

New Data from Ivosidenib Phase 1 Dose-Escalation and Expansion Trial Demonstrate Durable Responses in Patients with IDH1m Relapsed or Refractory AML

11/12/2017 - 22:00

- First Expansion Data and Updated Dose-Escalation Data Support NDA Submission for IDH1m R/R AML by Year End 2017 and Demonstrate Overall Efficacy and Safety Profile Consistent with Previously Reported Data - - In 125 R [...]

NAPA’s Jonathan Markley Named to Top Doctor’s list by New Jersey Monthly

11/12/2017 - 20:00

MELVILLE, N.Y., Dec. 11, 2017 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) announced today that one of its leading practitioners, Jonathan Markley, DO, was selected as a Top Doctor in the [...]

Fractured Truth Campaign Wins Bronze Pearl Award for Content Marketing Excellence in the Healthcare/Pharmaceutical Industry

11/12/2017 - 19:30

WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) today announced that Fractured Truth—an unbranded patient campaign aimed to educate younger postmenopausal women about risks [...]

FDA Approves Sanofi's Admelog® (insulin lispro injection)

11/12/2017 - 19:11

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA Approves Sanofi's Admelog ® (insulin lispro injection) First FDA-approved follow-on mealtime insulin Admelog (insulin lispro injection) 100 Units/mL will be [...]

La FDA approuve l'insuline lispro injectable Admelog® de Sanofi

11/12/2017 - 19:11

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) La FDA approuve l'insuline lispro injectable Admelog ® de Sanofi Première insuline prandiale « follow-on » [1] approuvée par la FDA Admelog (insuline [...]

U.S. Army Dental Corps Veteran Honored by the American College of Prosthodontists

11/12/2017 - 18:49

Chicago, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Ronald D. Woody, DDS, FACP , was honored with the Major General Bill B. Lefler Federal Services Award at the Annual Awards & President’s Dinner during the American College [...]

RedHawk Completes EcoGen Share Transfer Agreement

11/12/2017 - 18:26

LAFAYETTE, La., Dec. 11, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today that along with its wholly-owned subsidiary, RedHawk Pharma UK Limited (“RedHawk Pharma [...]

Almirall and Athenex announce strategic partnership for the treatment of actinic keratosis

11/12/2017 - 17:31

Almirall and Athenex have entered into a strategic partnership to develop and commercialize KX2-391 in the United States and Europe KX2-391 is a first-in-class topical treatment currently in Phase III development that [...]

Ossur Hf : Transactions in relation to share buyback program

11/12/2017 - 17:01

Announcement from Össur hf. No. 86/2017 Reykjavík, 11 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Novartis drug crizanlizumab shown to prolong time to patients' first sickle cell pain crisis in subgroup analysis of SUSTAIN study

11/12/2017 - 16:51

Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle cell pain crisis, according to new subgroup analysis of Phase II SUSTAIN data Results were [...]

Phase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Presented at 59th Annual ASH Meeting

11/12/2017 - 16:45

Encouraging initial anti-leukemic activity with durable responses and acceptable tolerability observed in dose expansion cohort Data supports combination with MGA012 (anti-PD-1) to potentially enhance anti-leukemic [...]